Ciprofibrate
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | C10AB08 (WHO) |
| Identifiers | |
| |
| CAS Number | 52214-84-3 |
| PubChem (CID) | 2763 |
| IUPHAR/BPS | 3438 |
| ChemSpider |
2661 |
| UNII |
F8252JGO9S |
| KEGG |
D03521 |
| ChEBI |
CHEBI:50867 |
| ChEMBL |
CHEMBL557555 |
| ECHA InfoCard | 100.052.478 |
| Chemical and physical data | |
| Formula | C13H14Cl2O3 |
| Molar mass | 289.154 g/mol |
| 3D model (Jmol) | Interactive image |
| Chirality | Racemic mixture |
| |
| |
| (verify) | |
Ciprofibrate is a fibrate that was developed as a lipid-lowering agent.
References
| GI tract |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Liver |
| ||||||||||
| Blood vessels |
| ||||||||||
| Combinations | |||||||||||
| Other | |||||||||||
| |||||||||||
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
